Who is sponsoring NCT05572385?

NCT05572385 is sponsored by Klinik Bavaria.

What drugs are being tested in NCT05572385?

Interventions in NCT05572385: CIAT + Conventional neurorehabilitative therapy.

What condition does NCT05572385 study?

NCT05572385 studies Aphasia, Acquired.

Is NCT05572385 still recruiting?

NCT05572385 is currently not yet recruiting. Last updated 7 October 2022.

Last reviewed 2022-10-07 · How we verify

NCT05572385: AphasRehab

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinic and Neurophysiology of Aphasia Treatment

Not yet recruiting NA Last updated 7 October 2022

What this trial tests

NA trial testing CIAT + Conventional neurorehabilitative therapy in Aphasia, Acquired in 40 participants. Not yet recruiting.

Timeline

1 July 2023

Primary endpoint
31 December 2025

31 December 2026

Quick facts

Lead sponsor	Klinik Bavaria
Phase	NA
Status	Not yet recruiting
Study type	INTERVENTIONAL
Allocation	non randomized
Design	factorial
Masking	none
Primary purpose	treatment
Enrollment	40
Start date	1 July 2023
Primary completion	31 December 2025
Estimated completion	31 December 2026

Drugs / interventions tested

CIAT + Conventional neurorehabilitative therapy

Conditions studied

Aphasia, Acquired — all drugs for Aphasia, Acquired →

Sponsor

Klinik Bavaria

Who can join

Eligibility, any sex, with Aphasia, Acquired. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In the planned study, clinical and electrophysiological features of aphasia recovery in stroke patients are investigated.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Aphasia, Acquired

Currently open trials in the same condition.

NCT07281313 — Aphasia Physical EXercise Study: Randomized Trial · NA · recruiting
NCT06842745 — Transcranial Magnetic Stimulation + Language Therapy to Treat Mild Aphasia · Phase 2 · recruiting
NCT06092814 — tACS to Enhance Language Abilities · NA · recruiting
NCT05667480 — VR and Script Training of PWA · NA · active not recruiting
NCT05443633 — Enhancing Language Function in Aphasia · NA · recruiting

Other Klinik Bavaria trials

Trials by the same sponsor.

NCT05529745 — Neurorehabilitation Impact on Neurocognitive Impairments in Cerebellar Lesions · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05572385 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Klinik Bavaria
Last refreshed: 7 October 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05572385.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing